Analysis of antiepileptic drugs use at a university hospital in Croatia

European Journal of Neurology

Volumn 12, Issue 6, 2005, Pages 483-485

  Prpic, Igor ^a,c   Vlahovic Palcevski, V ^a   Skarpa Prpic, I ^a   Palcevski, G ^a   Boban, M ^b  

^a KBC RIJEKA   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Antiepileptic drugs; Defined daily doses; Utilization

Indexed keywords

BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; GABAPENTIN; LAMOTRIGINE; METHYLPHENOBARBITAL; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ANTICONVULSANT ACTIVITY; ARTICLE; CROATIA; DOSE RESPONSE; EPILEPSY; HOSPITAL CARE; HUMAN; INTERNATIONAL COOPERATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

ANTICONVULSANTS; CROATIA; DRUG UTILIZATION REVIEW; EPILEPSY; HOSPITALS, UNIVERSITY; HUMANS; PHARMACOEPIDEMIOLOGY; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 20044395990     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2005.00994.x     Document Type: Article

References (15)

1. Angehagen M, Ben-Menachem E, Ronnback L, Hansson E (2003). Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate. Neurochem Res 28:333-340.
2. Babic T (2001). Rational pharmacotherapy of neurologic diseases. Oral presentation. Third Croatian Congress of Neurology, 10-13 October, Rijeka, Croatia.
3. Bergin AM, Connolly M (2002). New antiepileptic drug therapies. Neurology Clinics 20:1163-1167.
4. Brunbech L, Sabers A (2002). Effect of antiepileptic drugs on cognitive function in individuals with epilepsy - A comparative review of newer versus older agents. Drugs 62:593-604.
5. Calabresi P, Cupini LM, Centonze D, Pisani F, Bernardi G (2003). Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol 53:693-702.
6. Deckers CL, Knoester PD, de Haan GJ, Keyser A, Renier WO, Hekster YA (2003). Selection criteria for the clinical use of the newer antiepileptic drugs. CNS Drugs 17:405-421.
7. Dichter MA, Brodie MJ (1996). New antiepileptic drugs. N Engl J Med 334:1583-1590.
8. Evins AE (2003). Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders. J Clin Psychiatry 64:9-14.
9. French JA (2002). Postmarketing surveillance of new antiepileptic drugs: the tribulations of trials. Epilepsia 43:951-955.
10. Guidelines for ATC Classification and DDD Assignment (2002). WHO Collaborating Centre for Drug Statistics Methodology, Oslo.
11. Heaney DC, Shorvon SD, Sander JW et al. (2000). Cost minimization analysis of antiepileptic drugs in newly diagnosed epilepsy in 12 European countries. Epilepsia 41:S37-S44.
12. Perruca E (2001). The clinical pharmacology and therapeutic use of the new antiepileptic drugs. Fundam Clin Pharmacol 15:405-417.
13. Perruca E (2003). Current trends in antiepileptic drug therapy. Epilepsia 44:41-47.
14. Vajda FJE (2000). New antiepileptic drugs. J Clin Neurosci 7:88-101.
15. Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS (2001). Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 56:184-190.